Imricor Medical Systems, Inc. (ASX:IMR)
Australia
· Delayed Price · Currency is AUD 2.000
+0.005 (0.25%)
Mar 6, 2026, 4:10 PM AEST
Imricor Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 0.29 | 0.96 | 0.62 | 0.82 | 0.7 | Upgrade
|
| Revenue Growth (YoY) | -69.53% | 55.86% | -24.56% | 17.20% | -0.84% | Upgrade
|
| Cost of Revenue | 2.33 | 1.88 | 1.73 | 2.34 | 2.59 | Upgrade
|
| Gross Profit | -2.03 | -0.92 | -1.12 | -1.53 | -1.9 | Upgrade
|
| Selling, General & Admin | 9.6 | 7.19 | 7.82 | 7.79 | 8.69 | Upgrade
|
| Research & Development | 11.16 | 8.18 | 7.92 | 7.95 | 9.68 | Upgrade
|
| Operating Expenses | 20.76 | 15.37 | 15.74 | 15.73 | 18.36 | Upgrade
|
| Operating Income | -22.79 | -16.3 | -16.86 | -17.26 | -20.26 | Upgrade
|
| Interest Expense | -0 | -0.02 | -0.05 | -0.18 | -0.11 | Upgrade
|
| Interest & Investment Income | 1.18 | 0.26 | 0.06 | 0.11 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.51 | 0.2 | 0.01 | -0.02 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | -2.42 | -5.79 | -0.01 | -0.1 | Upgrade
|
| EBT Excluding Unusual Items | -20.17 | -18.28 | -22.63 | -17.36 | -20.49 | Upgrade
|
| Other Unusual Items | -5.14 | -11.42 | - | - | 0.76 | Upgrade
|
| Pretax Income | -25.32 | -29.69 | -22.63 | -17.36 | -19.73 | Upgrade
|
| Net Income | -25.32 | -29.69 | -22.63 | -17.36 | -19.73 | Upgrade
|
| Net Income to Common | -25.32 | -29.69 | -22.63 | -17.36 | -19.73 | Upgrade
|
| Shares Outstanding (Basic) | 309 | 224 | 157 | 146 | 131 | Upgrade
|
| Shares Outstanding (Diluted) | 309 | 224 | 157 | 146 | 131 | Upgrade
|
| Shares Change (YoY) | 37.84% | 43.03% | 7.46% | 11.42% | 18.76% | Upgrade
|
| EPS (Basic) | -0.08 | -0.13 | -0.14 | -0.12 | -0.15 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.13 | -0.14 | -0.12 | -0.15 | Upgrade
|
| Free Cash Flow | -19.52 | -15.65 | -13.06 | -16.75 | -18.11 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.07 | -0.08 | -0.12 | -0.14 | Upgrade
|
| Gross Margin | - | -96.32% | -181.27% | -187.10% | -272.30% | Upgrade
|
| Operating Margin | -7796.87% | -1698.60% | -2738.12% | -2115.18% | -2909.72% | Upgrade
|
| Profit Margin | -8661.58% | -3094.86% | -3675.61% | -2126.96% | -2834.05% | Upgrade
|
| Free Cash Flow Margin | -6676.31% | -1631.38% | -2121.66% | -2052.56% | -2601.63% | Upgrade
|
| EBITDA | -21.99 | -15.55 | -16.15 | -16.55 | -19.57 | Upgrade
|
| D&A For EBITDA | 0.8 | 0.75 | 0.71 | 0.71 | 0.69 | Upgrade
|
| EBIT | -22.79 | -16.3 | -16.86 | -17.26 | -20.26 | Upgrade
|
| Revenue as Reported | 0.29 | 0.96 | 0.62 | 0.82 | 0.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.